MDNN: AI Health Coaches, Opioid Replacements, HCV, and Peer Insights

Video

Stay updated on the biggest headlines with MDNN from November 10, 2017.

Hi, I’m Jenna Payesko, and this is MD Magazine News Network - it’s clinical news for connected physicians.

A new conversational artificial intelligence program is helping diabetic patients maintain a healthy weight. In a new study, 239 overweight or obese patients with type 2 diabetes reported an average 2.38% weight loss from baseline after using the Lark Health Coach, an automated text-based AI service. The program, which mimics empathic health counseling and monitors patient diet, sleep, and activity, could be amongst the first line of AI services designated to aid the 100 million Americans with prediabetes or diabetes.

A new study suggests that popular OTC medications Tylenol and Motrin could replace opioids in some emergency settings. A randomized study conducted in emergency departments in the Bronx found that an ibuprofen and acetaminophen combination doses are as efficacious for acute extremity pain relief as opioid combination therapies over a 2-hour span. The researchers are now pursuing grants to fund further research to investigate whether the common pain relief treatments are a suitable alternative to opioids in outpatient settings.

Sustained virologic response from Hepatitis C treatment does not depend on a specialist doctor, according to a phase 4 study of chronic HCV patients. In the study, patients who were given direct-acting antiviral Harvoni experienced consistent SVR rates when treated by primary care physicians, hepatology specialist physicians, or nurse practitioners.

Be sure to read these stories and all the latest breaking clinical news at www.mdmag.com

And now, please enjoy expert insights into emerging therapies in spondyloarthritis from Allan Gibofsky, MD.

For more clinical insights direct from the experts, visit mdmag.com/insights.

I’m Jenna Payesko for MDNN, thank you for watching.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
© 2024 MJH Life Sciences

All rights reserved.